Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase.

Jing Yang,Pengfei Li,Yingshi Piao,Xindi Liu,Liqiang Wei,Wei Sang,Luo Zhang,Liang Wang

Frontiers in immunology（2022）

Cited 2|Views17
No score
Abstract
CD56 negative NKTCL differs from CD56 positive NKTCL in both the tumor microenvironment and survival outcomes, and asparaginase-based treatment may overcome the poor prognosis brought by CD56 negativity.
More
Translated text
Key words
asparaginase,bioinformatics analysis,extranodal natural killer/T cell lymphoma,prognosis,tumor microenvironment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined